Positive trial results for Biogen Idec's MS drug BG-12The Pharma LetterIn fact, interest in BG-12, along with Biogen Idec's PEG-Avonex, Abbott/Biogen Idec's daclizumab and Roche/Genentech's ocrelizumab, has increased significantly compa…
Spectrum Begins Phase III ZEST Study – Analyst BlogNASDAQThe study aims to evaluate the product in patients suffering from diffuse large B-cell lymphoma (DLBCL) and who are in remission after R-CHOP chemotherapy (rituximab, cyclophosphamide, doxorubici…
Spectrum initiates patient enrollment in Phase III B-cell lymphoma trialEquities.comThe ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on the combined effect of …
Debunked: Scientists Find No Link Between Chronic Fatigue Syndrome and …Yahoo! News Blogs (blog)The biggest hope for people with CFS is probably Fluge and Mella's current drug trials with Rituximab which removes B cells from the blood. This is a …
Spectrum begins Phase 3 DLBCL trial of ZevalinPharmaceutical Business ReviewThe study will assess overall survival (OS) and progression-free survival (PFS) in patients 60 years and older with DLBCL who achieved remission following R-CHOP chemotherapy (…
Janssen Submits Application To FDA Requesting Approval Of SIMPONI …Sacramento BeeTell your doctor about all the medications you take including ORENCIA (abatacept), KINERET (anakinra), ACTEMRA (tocilizumab), RITUXAN (rituximab), or another TNF blocker…
Spectrum Pharmaceuticals Initiates Phase 3 Study of ZEVALIN® in Patients with …DailyFinance"DLBCL consolidation therapy is a setting in which rituximab maintenance has failed to show benefit in two randomized clinical trials, whereas multiple P…
SPECTRUM PHARMACEUTICALS, INC. : Spectrum Pharmaceuticals Initiates …4-traders"DLBCL consolidation therapy is a setting in which rituximab maintenance has failed to show benefit in two randomized clinical trials, whereas multiple Phase 2 studies…
Lundbeck Canada Offers New Treatment Option for Relapsed Indolent B-cell …R & D Magazine"For some patients with CLL, Treanda could result in much longer remission periods compared with chlorambucil. And for some patients with iNHL whose cancer h…
I3 Analytics' ClinicalTrials Navigator Sees A New Dawn For Multiple Sclerosis …Daily MarketsIn addition to the aforementioned drugs that are pending FDA approval, there are several promising therapies in the later stages of clinical development a…